A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. The study found the vaccine was still ...
About 100 people in the Netherlands reported developing side effects after receiving a COVID-19 vaccine developed by Pfizer/BioNTech, the NOS broadcaster reported on Friday, citing pharmacovigilance centre Lareb. Lareb director Agnes Kant told NOS that severe allergic reactions to the Pfizer shot were identified in two cases in the Netherlands. ...
